Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
VERSITECH Limited currently manages a portfolio with 6 pending office actions, all situated within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 6 distinct examiners, indicating a decentralized prosecution effort where each pending matter is being handled by a different individual. Despite this variety in examiners, the actions are concentrated within 3 distinct art units, suggesting that the underlying technologies are grouped into specific administrative categories.
The busiest examiner for the portfolio is MILLER, DALE R, who is currently responsible for 1 pending action. Given that there are 6 distinct examiners, the workload is balanced with each examiner managing 1 case. This structure may require the company to coordinate across multiple examiners to ensure consistency in their pharmaceutical patent strategies. With 3 distinct art units involved, the portfolio shows technical breadth within the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, DALE R | 1 | 62.4% | +17.5% |
| SHAH, NEEL D | 1 | 86.9% | +7.6% |
| DESTEFANO, AUDRA JEAN | 1 | 56.4% | +61.2% |
| OSINSKI, BRADLEY JAMES | 1 | 78.5% | +11.3% |
| LI, BAO Q | 1 | 75.4% | +26.8% |
| KUCHARCZK, JED A | 1 | 80.2% | +16.7% |
| RIGA, MICHAEL ANGELO | 1 | 57.1% | +61.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686153 | FABRICATION OF A SCALABLE QUANTUM SENSING DEVICE THROUGH PRECISELY PROGRAMMABLE PATTERNING SPIN DEFECTS ON UNIVERSAL SUBSTRATES | SHAH, NEEL D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261991 | A STEERABLE ARM FOR USE IN ENDOSCOPIC SURGICAL PROCEDURES | OSINSKI, BRADLEY JAMES | 30d |
| 18717355 | ANTIFUNGAL COMPOUND, COMPOSITION AND USES THEREOF | MILLER, DALE R | — |
| 18568727 | APPLICATION OF METALLO-SUPRAMOLECULAR BRANCHED POLYMERS IN CRYO-ELECTRON MICROSCOPY SAMPLE PREPARATION | DESTEFANO, AUDRA JEAN | — |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | LI, BAO Q | — |
| 17617895 | PURMORPHAMINE AS A SMALL COMPOUND POSITIVE ALLOSTERIC MODULATOR OF SECRETIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION | KUCHARCZK, JED A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17434513 | RECOMBINANT VECTORS COMPRISING ARYLSULFATASE A AND THEIR USES IN STEM CELL THERAPY FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY | RIGA, MICHAEL ANGELO | 87d overdue |
| 18261991 | A STEERABLE ARM FOR USE IN ENDOSCOPIC SURGICAL PROCEDURES | OSINSKI, BRADLEY JAMES | 30d |
| 18717355 | ANTIFUNGAL COMPOUND, COMPOSITION AND USES THEREOF | MILLER, DALE R | — |
| 18568727 | APPLICATION OF METALLO-SUPRAMOLECULAR BRANCHED POLYMERS IN CRYO-ELECTRON MICROSCOPY SAMPLE PREPARATION | DESTEFANO, AUDRA JEAN | — |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | LI, BAO Q | — |
| 17617895 | PURMORPHAMINE AS A SMALL COMPOUND POSITIVE ALLOSTERIC MODULATOR OF SECRETIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION | KUCHARCZK, JED A | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| 1671 | 1 |
| 1623 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717355 | ANTIFUNGAL COMPOUND, COMPOSITION AND USES THEREOF | MILLER, DALE R | — | §101§102§103 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18686153 | FABRICATION OF A SCALABLE QUANTUM SENSING DEVICE THROUGH PRECISELY PROGRAMMABLE PATTERNING SPIN DEFECTS ON UNIVERSAL SUBSTRATES | SHAH, NEEL D | — | §103 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18568727 | APPLICATION OF METALLO-SUPRAMOLECULAR BRANCHED POLYMERS IN CRYO-ELECTRON MICROSCOPY SAMPLE PREPARATION | DESTEFANO, AUDRA JEAN | — | §102§103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18261991 | A STEERABLE ARM FOR USE IN ENDOSCOPIC SURGICAL PROCEDURES | OSINSKI, BRADLEY JAMES | 3783 | §103§112 | Final Rejection | 30d | Pending | Jul 18, 2023 |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | LI, BAO Q | 1671 | §102§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 17617895 | PURMORPHAMINE AS A SMALL COMPOUND POSITIVE ALLOSTERIC MODULATOR OF SECRETIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION | KUCHARCZK, JED A | 1623 | §102§103§112 | Final Rejection | — | Pending | Dec 09, 2021 |
| 17434513 | RECOMBINANT VECTORS COMPRISING ARYLSULFATASE A AND THEIR USES IN STEM CELL THERAPY FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY | RIGA, MICHAEL ANGELO | 1634 | §103 | Final Rejection | 87d overdue | Pending | Aug 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial